Improving total-cholesterol/HDL-cholesterol ratio results in an endothelial dysfunction recovery in peripheral artery disease patients

Cholesterol

Volumn 2012, Issue , 2012, Pages

  Bleda, Silvia ^a   De Haro, Joaquín ^a   Varela, César ^a   Esparza, Leticia ^a   Rodriguez, Javier ^a   Acin, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRITE;

ANALYTICAL PARAMETERS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TOTAL CHOLESTEROL HDL CHOLESTEROL RATIO; TREATMENT DURATION;

EID: 84867775556     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2012/895326     Document Type: Article

References (40)

1. Ross R., Atherosclerosisan inflammatory disease. The New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207 (Pubitemid 29054847)
2. De Haro J., Acín F., López-Quintana A., Direct assotiation between C-reactive protein serum levels and endothelial dysfunction in patients with claudication. European Journal of Vascular and Endovascular Surgery 2008 35 480 486 (Pubitemid 351296162)
3. De Haro J., Martínez-Aguilar E., Florez A., Varela C., Bleda S., Acin F., Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs. Interactive Cardiovascular and Thoracic Surgery 2009 9 1 107 112 2-s2.0-67650156439 10.1510/icvts.2008.196428
4. Ignarro L. J., Cirino G., Casini A., Napoli C., Nitric oxide as a signaling molecule in the vascular system: an overview. Journal of Cardiovascular Pharmacology 1999 34 6 879 886 2-s2.0-0032707717 10.1097/00005344-199912000-00016
5. Zulli A., Hare D. L., Buxton B. F., Black M. J., High dietary methionine plus cholesterol exacerbates atherosclerosis formation in the left main coronary artery of rabbits. Atherosclerosis 2004 176 1 83 89 2-s2.0-4043155719 10.1016/j.atherosclerosis.2004.05.013 (Pubitemid 39078648)
6. Creager M. A., Cooke J. P., Mendelsohn M. E., Gallagher S. J., Coleman S. M., Loscalzo J., Dzau V. J., Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. Journal of Clinical Investigation 1990 86 1 228 234 2-s2.0-0025307354 (Pubitemid 20226996)
7. Mullen M. J., Kharbanda R. K., Cross J., Donald A. E., Taylor M., Vallance P., Deanfield J. E., MacAllister R. J., Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circulation Research 2001 88 2 145 151 2-s2.0-0035793340 10.1161/01.RES.88.2.145 (Pubitemid 32147301)
8. Zeiher A. M., Drexler H., Saurbier B., Just H., Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. Journal of Clinical Investigation 1993 92 2 652 662 2-s2.0-0027249912 10.1172/JCI116634 (Pubitemid 23262382)
9. Böger R. H., Association of asymmetric dimethylarginine and endothelial dysfunction. Clinical Chemistry and Laboratory Medicine 2003 41 11 1467 1472 2-s2.0-0344306684 10.1515/CCLM.2003.225 (Pubitemid 37493562)
10. Ansell B. J., Watson K. E., Fogelman A. M., Navab M., Fonarow G. C., High-density lipoprotein function: recent advances. Journal of the American College of Cardiology 2005 46 10 1792 1798 2-s2.0-27644587961 10.1016/j.jacc.2005.06.080 (Pubitemid 41579798)
11. Davignon J., Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004 109 23 supplement 1 III39 III43 2-s2.0-2942720515 (Pubitemid 38786442)
12. Gordon D. J., Rifkind B. M., High-density lipoproteinthe clinical implications of recent studies. The New England Journal of Medicine 1989 321 19 1311 1316 2-s2.0-0024449985 (Pubitemid 19267219)
13. Assmann G., Gotto A. M., HDL cholesterol and protective factors in atherosclerosis. Circulation 2004 109 23 supplement 1 III8 III14 2-s2.0-2942750054 (Pubitemid 38786437)
14. Li X. P., Zhao S. P., Zhang X. Y., Liu L., Gao M., Zhou Q. C., Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. International Journal of Cardiology 2000 73 3 231 236 2-s2.0-0034737948 10.1016/S0167-5273(00)00221-7 (Pubitemid 30332325)
15. Kuvin J. T., Patel A. R., Sidhu M., Rand W. M., Sliney K. A., Pandian N. G., Karas R. H., Relation between high-density lipoprotein cholesterol and peripheral vasomotor function. American Journal of Cardiology 2003 92 3 275 279 2-s2.0-0042848537 10.1016/S0002-9149(03)00623-4 (Pubitemid 36897708)
16. Ray K. K., Cannon C. P., Cairns R., Morrow D. A., Ridker P. M., Braunwald E., Prognostic utility of ApoB/AI, total cholesterol/HDL, Non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes results from PROVE IT-TIMI 22. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 3 423 430 2-s2.0-61549120401 10.1161/ATVBAHA.108.181735
17. Keil U., Liese A. D., Hense H. W., Filipiak B., Döring A., Stieber J., Löwel H., Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. European Heart Journal 1998 19 8 1197 1207 2-s2.0-0032147051 10.1053/euhj.1998.1089 (Pubitemid 28362603)
18. Real J. T., Chaves F. J., Martínez-Usó I., García-García A. B., Ascaso J. F., Carmena R., Importance of HDL cholesterol levels and the total/HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia. European Heart Journal 2001 22 6 465 471 2-s2.0-0034931412 10.1053/euhj.2000.2408 (Pubitemid 32619619)
19. Myoishi M., Hao H., Minamino T., Watanabe K., Nishihira K., Hatakeyama K., Asada Y., Okada K. I., Ishibashi-Ueda H., Gabbiani G., Bochaton-Piallat M. L., Mochizuki N., Kitakaze M., Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation 2007 116 11 1226 1233 2-s2.0-34948866189 10.1161/CIRCULATIONAHA.106.682054 (Pubitemid 47517533)
20. Wang N., Silver D. L., Costet P., Tall A. R., Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. Journal of Biological Chemistry 2000 275 42 33053 33058 2-s2.0-0034693064
21. Newman A. B., Shemanski L., Manolio T. A., Cushman M., Mittelmark M., Polak J. F., Powe N. R., Siscovick D., Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health study. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 3 538 545 2-s2.0-0033012553 (Pubitemid 29135153)
22. National Heart, Lung, and Blood Institute, Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III, or ATPIII). 2006
23. Verdecchia P., Angeli F., The seventh report of the joint national committee on the prevention, detection, evaluation and treatment of high blood pressure: the weapons are ready. Revista Espanola de Cardiologia 2003 56 9 843 847 2-s2.0-0242440925 10.1157/13051609 (Pubitemid 37407081)
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2001 24 supplement 1 5 20
25. Ferrer R., Hernández Jara J., Chronic renal insufficiency. I: definition, clinical course stages, progression mechanisms, etiology, and diagnostic criteria. Nefrologia 2001 21 18 20 2-s2.0-2242463066
26. Kleinbongard P., Rassaf T., Dejam A., Kerber S., Kelm M., Griess method for nitrite measurement of aqueous and protein-containing samples. Methods in Enzymology 2002 359 158 168 2-s2.0-0036437091 10.1016/S0076-6879(02)59180-1 (Pubitemid 35387018)
27. Allain C. C., Poon L. S., Chan C. S. G., Enzymatic determination of total serum cholesterol. Clinical Chemistry 1974 20 4 470 475 2-s2.0-0016373654
28. ter Welle H. F., Baartscheer T., Fiolet J. W., Influence of free glycerol on enzymic evaluation of triglycerides. Clinical Chemistry 1984 30 6 1102 1103 2-s2.0-0021448003
29. Burstein M., Scholnick H. R., Morfin R., Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Journal of Lipid Research 1970 11 6 583 595 2-s2.0-0014876627
30. Havel R. J., Eder H. J., Bragdon J. H., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. The Journal of clinical investigation 1955 34 9 1345 1353 2-s2.0-33745026603
31. Rasmusen C., Cynober L., Couderc R., Arginine and statins: relationship between the nitric oxide pathway and the atherosclerosis development. Annales de Biologie Clinique 2005 63 5 443 455 2-s2.0-30744435355 (Pubitemid 43093443)
32. Rosenblat M., Hayek T., Hussein K., Aviram M., Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1 175 180 2-s2.0-0347753257 10.1161/01.ATV.0000104011.88939.06 (Pubitemid 38082430)
33. Harangi M., Seres I., Varga Z., Emri G., Szilvássy Z., Paragh G., Remenyik E., Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage. European Journal of Clinical Pharmacology 2004 60 10 685 691 2-s2.0-12444339797 10.1007/s00228-004-0820-6
34. Bleda S., de Haro J., Florez A., Varela C., Esparza L., Acin F., Long-term pleiotropic effect of statins upon nitric oxide and C-reactive protein levels in patients with peripheral arterial disease. Heart Asia 2011 3 130 134
35. Kureishi Y., Luo Z., Shiojima I., Bialik A., Fulton D., Lefer D. J., Sessa W. C., Walsh K., The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nature Medicine 2000 6 9 1004 1010 2-s2.0-0033826581 10.1038/79510
36. Rikitake Y., Liao J. K., Rho GTPases, statins, and nitric oxide. Circulation Research 2005 97 12 1232 1235 2-s2.0-33644694919 10.1161/01.RES.0000196564.18314.23
37. Reriani M. K., Dunlay S. M., Gupta B., Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials. European Journal of Cardiovascular Prevention and Rehabilitation 2011 18 5 704 716
38. Murrow J. R., Sher S., Ali S., The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. Journal of Clinical Lipidology 2012 6 1 42 49
39. Sugiura T., Dohi Y., Yamashita S., Yamamoto K., Wakamatsu Y., Tanaka S., Kimura G., Impact of lipid profile and high blood pressure on endothelial damage. Journal of Clinical Lipidology 2011 5 6 460 466 2-s2.0-79960467022 10.1016/j.jacl.2011.06.005
40. Kleinbongard P., Dejam A., Lauer T., Rassaf T., Schindler A., Picker O., Scheeren T., Gödecke A., Schrader J., Schulz R., Heusch G., Schaub G. A., Bryan N. S., Feelisch M., Kelm M., Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radical Biology and Medicine 2003 35 7 790 796 2-s2.0-10744229717 10.1016/S0891-5849(03)00406-4 (Pubitemid 37329482)